Interní Med. 2011; 13(4): 182-185

On the dosage of diuretics in hypertension treatment

doc.MUDr.Jiří Špác, CSc., MUDr.Bohuslav Kianička
2. interní klinika, LF MU a FN u sv. Anny v Brně

Diuretics are among the longest-used major drug groups in hypertension treatment, having been used in the clinical practice since 1957

until now for their capacity to effectively reduce blood pressure levels. In hypertension treatment, they are primarily used in combination

with other antihypertensive drugs in low doses. Increasing the dose of thiazide diuretics is not effective in terms of hypertension

treatment and does not result in increased effect; on the contrary, there is accentuation of side effects. Minimizing the daily dose of

diuretics is one of the main approaches in order to prevent negative metabolic consequences.

Keywords: hypertension treatment, diuretics

Published: April 13, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Špác J, Kianička B. On the dosage of diuretics in hypertension treatment. Interní Med. 2011;13(4):182-185.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Chapman AB, Schwartz GL, Boerwinkle E, Turner ST. Predictors of antihypertensive response to a standard dose of hydrochlorothiazide for essential hypertension. Kidney Int. 2002; 61: 1047-1055. Go to original source... Go to PubMed...
    2. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991; 265: 3255-3264. Go to original source...
    3. Dahlof B, Sever PS, Poulter NR, et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial - Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet 2005; 366: 895-906. Go to original source... Go to PubMed...
    4. Sica DA. Chlorthalidone: Has It Always Been the Best Thiazide-Type Diuretic? Hypertension 2006; 47: 321-322. Go to original source... Go to PubMed...
    5. Ernst ME, Carter BL, Goerdt CJ, et al. Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressure. Hypertension 2006; 47: 352-358. Go to original source... Go to PubMed...
    6. Kaplan NM. The Choice of Thiazide Diuretics: Why Chlorthalidone May Replace Hydrochlorothiazide Hypertension 2009; 54(5): 951-953. Go to original source... Go to PubMed...
    7. Psaty, M. Meta-analysis of Health Outcomes of Chlorthalidone-Based vs Nonchlorthalidone-Based Low-Dose Diuretic Therapies. JAMA 2004; 292: 43-44. Go to original source... Go to PubMed...
    8. Messerli F, Makani H, Benjo A, et al. Antihypertensive efficacy of HCTZ as evaluated by ABPM. A meta-analysis of randomized trials. J Am Coll Cardiol 2011; 57: 590-600. Go to original source... Go to PubMed...
    9. Schini VB, De Mey J, Vanhoutte PM. Effect of indapamide on endothelium-dependent relaxations in isolated canine femoral arteries. Am J Cardiol 1990; 65: 7H-10H. Go to original source... Go to PubMed...
    10. Psaty BM, Smith NL, Siscovick DS, et al. Health Outcomes Associated With Antihypertensive Therapies Used as FirstLine Agents: A Systematic Review and Meta-analysis. JAMA 1997; 277(9): 739-745. Go to original source...
    11. Souček M. Léčba hypertenze fixní kombinací. Interní Med., 2009; 11(9): 369-373.

    Return to the content


    Internal Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.